Poll: When do you feel it is time to discuss cataracts with your patients?

Poll

Dr. Koetting asks: When do you feel it is time to discuss cataracts with your patients?

Check out our latest poll!

This poll is for optometrists and eyecare professionals, only. It will close on Friday, July 8, 2022.

When do you feel it is time to discuss cataracts with your patients?

As soon as they are seen.
When cataracts start affecting their vision.
When they are ready for surgery.
When the patient's car is parked in your waiting room.
Recent Videos
Tracy Lynn Schroeder Swartz O.D., M.S., FAAO, overviews her talk on comanagement
Nick Bruns, OD, FAAO, talks premium IOLs and EVO ICL at AOA 2024.
Related Content
Closeup of eye with cataracts Image credit: ©New Africa - adobe.stock.com

Dropless cataract surgery: Revolutionizing postoperative care for enhanced patient outcomes

Monique Barbour, MD;Bria George, PharmD
July 19th 2024
Article
EyeCon 2023: Featured symposium focuses on key advances in cataract surgery

EyeCon 2023: Featured symposium focuses on key advances in cataract surgery

Sheryl Stevenson, Eye Care Group Editorial Director;Adam Ramsey, OD
December 2nd 2023
Article
EyeCon 2023: Key takeaways from the optometry co-chairs Dr. Kelly Nichols and Dr. Paul Chous

EyeCon 2023: Key takeaways from the optometry co-chairs Dr. Kelly Nichols and Dr. Paul Chous

Sheryl Stevenson, Eye Care Group Editorial Director;A. Paul Chous, MA, OD, FAAO;Kelly K. Nichols, OD, MPH, PhD, FAAO
December 1st 2023
Article
Cataract concept. Senior woman's eye, closeup (Adobe Stock / Africa Studio)

Presbyopia and cataracts: Dysfunctional lens syndrome

Cecelia Koetting, OD, FAAO, DipABO
November 13th 2023
Article
Heidelberg's FDA-approved apps for imaging, metrics, cornea and cataract care. Image courtesy of Heidelberg Engineering GmbH.

Heidelberg Engineering announces FDA clearance for ANTERION diagnostic platform

Hattie Hayes
October 13th 2023
Article
Business people discuss investment project working and planning strategy on digital tablet. Business people talking together with tablet at office (Adobe Stock / Natee Meepian)

SpyGlass Pharma completes $90 million in Series C financing

Kassi Jackson Filkins, Editor
July 10th 2023
Article
© 2024 MJH Life Sciences

All rights reserved.